| 摘要 |
The present invention relates to a novel form of a dual-target antibody targeting VEGFR-2 and DLL4, a gene encoding the same, a recombinant expression vector including the gene, host cells transformed with the recombinant expression vector, a method of producing the dual-target antibody using the host cells, a pharmaceutical composition comprising the dual-target antibody. |
| 申请人 |
PHARMABCINE INC. |
发明人 |
KIM, JOONG KYU;YOO, JIN SAN;LEE, SANG HOON;LEE, WEON SUP;KIM, SUNG WOO;SHIM, SANG RYEOL;YOO, JIN SANG;LEE, YOUNG AE;PARK, MI JU;BYUN, SANG SOON;LEE, HYUK JOON;KIM, DO YUN;KIM, YEUN JU;CHOI, JIN HEE;NAHM, KYUNG HEE;NAM, JU RYUNG;JEONG, JONG GEUN;JEONG, BO YOUNG;LEE, EUN JIN;LEE, SEON YOUNG;PARK, IN SOOK;LEE, JIN SOOK;YOON, JAE BONG;KIM, NAM YE;OH, SEON HWAN |
